About Nuclear factor 1 C-type
Nuclear factor 1 C-type (NFIC) is a protein
from Homo sapiens identified by UniProt accession
P08651, 508 residues long.
MolForge cross-references it against 0 known binders and
365 disease associations.
Target properties
| Protein name | Nuclear factor 1 C-type |
| UniProt accession | P08651 |
| Gene | NFIC |
| Organism | Homo sapiens |
| Length | 508 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (365)
Diseases linked to this target (Open Targets).
- sex hormone-binding globulin measurement · score 0.47
- heel bone mineral density · score 0.46
- body height · score 0.42
- eosinophil count · score 0.37
- platelet count · score 0.37
- high density lipoprotein cholesterol measurement · score 0.37
- neurodegenerative disease · score 0.36
- bone quantitative ultrasound measurement · score 0.35
- monocyte count · score 0.32
- body weight · score 0.32
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P08651-F1 | alphafold | PREDICTED | 60.88 | — |
Amino-acid sequence (508 residues)
MYSSPLCLTQ DEFHPFIEAL LPHVRAFAYT WFNLQARKRK YFKKHEKRMS KDEERAVKDE LLGEKPEVKQ KWASRLLAKL RKDIRPECRE DFVLSITGKK APGCVLSNPD QKGKMRRIDC LRQADKVWRL DLVMVILFKG IPLESTDGER LVKAAQCGHP VLCVQPHHIG VAVKELDLYL AYFVRERDAE QSGSPRTGMG SDQEDSKPIT LDTTDFQESF VTSGVFSVTE LIQVSRTPVV TGTGPNFSLG ELQGHLAYDL NPASTGLRRT LPSTSSSGSK RHKSGSMEED VDTSPGGDYY TSPSSPTSSS RNWTEDMEGG ISSPVKKTEM DKSPFNSPSP QDSPRLSSFT QHHRPVIAVH SGIARSPHPS SALHFPTTSI LPQTASTYFP HTAIRYPPHL NPQDPLKDLV SLACDPASQQ PGPLNGSGQL KMPSHCLSAQ MLAPPPPGLP RLALPPATKP ATTSEGGATS PTSPSYSPPD TSPANRSFVG LGPRDPAGIY QAQSWYLG
Explore Nuclear factor 1 C-type with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets